Lanxess Acquires PTAP Product Line

Lanxess has acquired the Nipacide PTAP product line from Clariant .The active ingredient p-tert-amylphenol (PTAP) complements the phenolic active ingredients portfolio of Lanxess' Material Protection Products (MPP) business unit. The parties have agreed not to disclose financial details of the transaction. Lanxess will market the active ingredient under the tradename Preventol PTAP. It can be used alone or in combination with ortho-phenylphenol (Preventol O extra) and chlorophen (Preventol BP), which are also marketed by MPP, in hospital, household, industrial and veterinary disinfectants.

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
19.03.2025 • TopicsStrategy

Substances of Concern

The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.